growth deep dive rais po post
rais po
last week mdt head emea rob ten hoedt senior investor relat team
ryan weispfen mark wilterd present healthcar confer
london follow meet thoroughli re-examin revenu
headwind tailwind face next month come away
convinc continu deliv revenu margin ep growth
promis forese futur view translat addit
multipl expans rais po base sens
cleanli deliv promis allow close valuat gap
peer new target assum trade previous calendar
ep discount larg cap peer
basic call consist deliv promis along improv free
cash flow matter well model well understood come
deceler revenu growth growth slow recent level current
pipelin allow growth remain rang long term
mani larger shot goal hypertens renal pillcam mitral materi
could upsid
insid note detail look headwind tailwind face
next month confid model revenu
growth model model
model full year model model
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
medic devic compani
oper four busi segment cardiac
diabet group minim invas therapi
buy rate continu believ
cov deal lower risk profil
better posit win new healthcar
environ longer term exposur
major med-tech growth market see
enough pipelin deliv
revenu growth ep growth go
major restructur near term would
increas investor expect leverag
mdt underli organ revenue growth acceler impress
last quarter repres signific uptick underli trend growth
allow appreci ytd go forward growth slow due tougher
comp increment competit well known well model call
consist deliv revenu margin earn combin
improv free cash flow growth drive multipl expans
new po assum trade discount peer
note quantifi headwind tailwind face
bofaml estim organ revenue growth need hit consensu report revenu
higher end
signific headwinds/tailwind rest
de total grew driven onyx
de launch anniversari view de could repres
increment y/i drag exactli model
tavr total grew
risk data help tough comp could make tavr
increment y/i drag total
mitg segment total grew
mitg face weak comp due hurrican impact tough comp
mitg could repres increment y/i drag view
af total grew driven dt lvad
approv due tough comp af could repres
increment y/i drag total
power total grew
driven steadi share gain micra pacemak micra truli
differenti view think growth unlik acceler much
near-term mdt power biz could repres modest
increment y/i drag total view
diabet segment total grew
view guardian connect drive growth tough comp
could result modest increment y/i drag growth view
high power total declin
driven competit mri-saf launch weak comp tyrx
wrap-it data fiscal could potenti drive increment y/i
growth total
spine total declin grew
view acceler trend growth weak comp robot spine
platform navig launch jan could result spine ad
increment y/i growth total view
spinal cord total nearli flat grew
driven intelli launch face weak comp intelli
anniversari view could add increment y/i
growth total
stroke cathet impress might
diabet segment total view competit
could slowdown mdt diabet growth start mid-calendar
begin mdt fiscal competit could repres
increment y/i drag total growth view
spinal cord total tougher comp driven share
gain intelli launch suggest us could
repres increment y/i drag total growth view
tavr total risk approv tailwind tavr market
like smoother step function view midteen growth
would impli tavr increment y/i drag total growth
mitg segment total mitg segment growth like
acceler view given new robot launch sever
product launch mitg grow vs estim
would repres increment y/i growth total view
high power total tyrx/wrap-it tailwind like
continu thru view mdt high power busi declin
vs estim declin would repres
increment y/i growth total
power total micra share gain like continu
view micraav launch could acceler trend growth
mdt power busi grow vs estim would
repres increment y/i growth total
tabl model mdt busi major product rest
detail put take segment
cvg segment total
mdt cvg segment grew guidanc segment
call growth growth impli
mdt high power busi declin past quarter
roughli hsd averag discuss previou note much
declin attribut declin overal market also recent
competit mri-saf launch launch septemb
view high power pressur continu persist eas
back half mdt fiscal lap mri-saf launch
year ago period view weak comp tyrx wrap-it data fiscal
could potenti drive increment y/i growth total remain
quarter
broader pressur high power busi could lessen bring new
innov market extravascular ev- calendar
unlik abruptli turnaround interim view
mdt power busi consist growth driver mdt
cvg segment total past quarter primarili due januari
launch micra leadless pacer number reason micra
differenti well power market despit anniversari
launch among biggest reason
micra smallest pacemak leadless pacemak
market benefit leadless significantli reduc
complic rate associ tradit ipg/lead implant
competitor significantli behind bring competit system
market give runway continu grow faster market
reimburs micra roughli price tradit pacer
us significantli incentiv provid use devic
seen tabl averag ww low power growth acceler
last quarter vs averag growth flat preced
quarter despit launch anniversari alreadi view trend
unlik slow much given novel concept micra is/how favor
reimburs fact micra singl chamber current mean
current serv pacer market howev plan launch
next-gen micra av fiscal calendar would expand micra
applic pacer market also serv acceler growth
line
view growth unlik acceler much near-term micraav
launch view mdt power busi could repres modest
drag remain quarter anoth modest increment growth
contribut
mdt linq implant cardiac monitor icm diagnost devic busi
recent face new competit confirm icm launch begin
face upcom competit lux-dx icm launch ww
worth note dilig confirm devic suggest
better technolog continu grow franchis confirm short batteri
life year less robust function limit impact linq growth
view linq continu grow m-hsd comp-adjust growth area even
lux-dx launch sometim calendar also note plan
launch next gen linq devic next month help off-set
competit pressur abt/bsx
tavr busi repres total cvg segment
despit recent tavr market share gain especi ou provid price-
pressur away ew premium valv largest competitor space tavr
continu repres drag overal growth given slow global
market expect risk data ew posit
impact market view uptak risk tavr patient could
smooth vs step-funct chang continu debat tavr
commun appropri tavr vs surgic aortic valv replac
younger patient especi unique/bicuspid anatomi
view mdt tavr busi could repres roughli increment drag
y/i growth averag remain quarter drag
pronounc steadili decreas quarter mdt
tavr busi could repres drag growth
seen tabl mdt onyx de launch us last year one
fundament driver cvg total organ growth ever sinc launch
may mdt de growth continu strong onyx
launch anniversari repres materi increment drag
total growth
view mdt de busi could add modest increment y/i growth
fiscal could repres increment drag growth
rtg segment total
mdt rtg segment grew grew due weak comp
share gain intelli launch guidanc call growth
growth full year view guidanc seem achiev
growth driven deep brain spine growth
driven neurovascular spine aspir cathet launch integr
navig platform launch mazor
ww market grew calendar mdt fiscal repres strong
consist sequenti growth comp adjust basi backdrop bode well
mdt intelli recent launch fulli global initi delay due
hurrican maria result share gain busi
declin msd-to-mid-teen launch intelli mdt busi
flat fiscal grew
similar last quarter weak comp mdt fiscal could result
busi ad increment point y/i growth total howev like
repres drag growth fiscal seem like
view intelli launch anniversari comp get tougher fiscal
mdt busi also like repres drag view estim
total growth fiscal tough comp fiscal
dont see truli groundbreak launch similar intelli launch happen
fiscal
mdt db busi declin view mdt db
busi continu declin lsd next coupl quarter underli trend
growth start pick launch deep brain stim epilepsi us
well primari cell sens next month view deep brain stim
could add increment growth fiscal given weak comp
increment growth contribut beyond fiscal unlik gamechang
view could amount basi point depend uptak new launch
mdt stroke busi steadi high-teen grower recent
quarter put growth growth
analyst day year highlight strong posit stroke immin
move ischem stroke aspir system riptid system recent
launch new stroke cathet new pump view might off-set
acceler mdt neurovascular busi might otherwis seen
plan launch new cathet later calendar year mdt fiscal
nevertheless continu expect mdt neurovascular/strok busi
maintain/acceler underli trend growth slightli balanc
overal market penetr ischem stroke increas time
mdt spine ex biolog busi declin grew
repres signific uptick underli trend growth busi
view weak comp acceler trend growth robot spine platform
navig launch januari could result spine ad
increment growth remaind view potenti higher
end fiscal first full quarter contribut robot
spine platform navig launch view mdt spine busi
continu trend acceler comp adjust growth new navig system
launch seem true competit advantag spine market dilig
suggest start contract hospit launch
mitg segment total
mdt mitg segment grew ahead guidanc
mitg guidanc full year guidanc
segment guidanc impli mitg growth
repres slowdown vs given tougher comp
recent growth mitg segment driven surgic innov
subseg specif launch signia power surgic
stapl system new ligasur vessel seal instrument view two
product line continu accret mitg total mdt top-line fiscal
mitg abl add point increment growth
hurrican impact year ago period howev tough comp given signia
ligasur launch could result mitg increment drag
total growth
look fiscal mitg segment sever upcom product launch
anticip surgic robot launch launch includ
colorect stapler multipass hemodialysi system plan offer
robot platform similar isrg da vinci system function view
launch still success pull mitg growth beyond
flexibl price robot hospit given
preexist contractu relationship provid
diabet segment total
expect diabet franchis grow l-mid teen long-term guidanc
less specif suggest diabet grow corpor averag
diabet guidanc doabl view growth slow meaning
late competit heat comp get difficult
reli rise market tide sheer market power diabet servic provid
competit tandem ratchet meaning view
note recent seagrov partner diabet patient survey suggest posit
trend overal cgm market well mdt sugar iq guardian connect
seagrov survey found non-cgm user plan start use cgm
next year get insur coverag patient said
sugar iq could caus start use guardian connect
tabl diabet signific growth contributor recent quarter
total revenu
total growth come diabet
term autom insulin deliveri step behind
control iq launch view today new technolog clearli drive acceler
diabet market growth importantli well proven contract servic
strength real competit advantag
term pipelin plan non-adjunct pma plan
submit manufactur control fall get clinic studi earli
next calendar year calibr
one reason confid least grow corpor averag
guardian connect contribut start zero pump
patient ad cgm
think two alon could provid point growth mdt diabet busi
expand market like put growth share loss could
limit upsid much beyond level
guardian connect enter stand-alone cgm market expect rapid
uptak product given featur disadvantag still requir fingerstick
think gain share market given breadth
diabet franchis estim could gain increment revenu per
year gain share fast grow market add point growth
total diabet franchis math
increas attach cgm mdt pump user also use cgm
renew go cgm-enabl pump increment cgm use
add around per year per patient estim around pump patient
us come renew year captur around
renew in-lin industri averag renew rate around
patient renew year estim patient year order cgm
first time add revenu point diabet growth
also rep tndm
cgm technolog superior view could limit uptak
stand-alone sensor comparison also becom tougher later fiscal
competit intensifi meaning start late fiscal new
tndm control iq algorithm automat adjust basal insulin prevent high low
blood sugar also deliv automat correct bolus bring high
blood sugar automat adjust basal insulin like control iq
bolu featur launch around
could potenti start take share control iq launch view
patient upgrad free control iq warranti result
patient may choos control iq control iq offici
also benefit work non-adjunct claim
requir calibr mdt still requir fingerstick doctor told
us patient stick day dilig also suggest patient
troubl stay auto mode
one thing consid qualiti tandem iq data least suggest
possibl break mdt exclus unit healthcar think
like given data possibl view
tabl diabet pipelin
sugar iq app watson
price object base trade cy ep
slight discount peer still think small discount group
warrant given recent execut misstep sever revenu headwind
upsid risk price object greater-than-expect revenu growth new
product robot develop market share gain competit product delay
acceler end-market growth downsid risk price object
competit share loss and/or price pressur
bob hopkin herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
becton dickinson compani
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
